Loading…
In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants
An animal model was used to study the effects of oral treatment with a small molecular selective inhibitor of cysteine proteinases, Z-Phe-Arg-fluoromethylketone (Z-Phe-Arg-FMK) on primary tumour development. Poorly differentiated rapidly growing and moderately differentiated slowly growing human pan...
Saved in:
Published in: | British journal of cancer 2000-02, Vol.82 (4), p.931-936 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c482t-e203526cdde650fa0e612433c1f7a95d78ee9dd22fe24732cf6c295d13934df73 |
---|---|
cites | |
container_end_page | 936 |
container_issue | 4 |
container_start_page | 931 |
container_title | British journal of cancer |
container_volume | 82 |
creator | Van Noorden, C J F Jonges, T G N Meade-Tollin, L C Smith, R E Koehler, A |
description | An animal model was used to study the effects of oral treatment with a small molecular selective inhibitor of cysteine proteinases, Z-Phe-Arg-fluoromethylketone (Z-Phe-Arg-FMK) on primary tumour development. Poorly differentiated rapidly growing and moderately differentiated slowly growing human pancreatic tumours were implanted in the neck of nude mice that were orally treated or not with the inhibitor. Growth rates of the tumours were determined during 38 days after implantation. The poorly differentiated tumours were not affected by treatment with the inhibitor. Development of the moderately differentiated tumours was inhibited significantly by Z-Phe-Arg-FMK treatment. Moreover, the amount of stroma was increased and the volume of cancer cells was reduced in the moderately differentiated tumours that had grown in the treated animals. Reduction in size of the tumours was not achieved by reduction in growth rate but in a delay of the onset of growth. It is concluded that cysteine proteinases play a transient role at the start of tumour development only when cancer cells are surrounded by stroma as was the case in the moderately differentiated but not in the poorly differentiated pancreatic tumours. However, this role of cysteine proteinases can easily be taken over by other proteinases. © 2000 Cancer Research Campaign |
doi_str_mv | 10.1054/bjoc.1999.1021 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2374406</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70973301</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-e203526cdde650fa0e612433c1f7a95d78ee9dd22fe24732cf6c295d13934df73</originalsourceid><addsrcrecordid>eNp1kU1v1DAQhi0EokvhyhFZCHHL1h9JHF-QUNVCpUpc4Gx5ncnGq6wdbGfL_nts7YoWJE6e8Tx-Z8YvQm8pWVPS1FebnTdrKqXMKaPP0Io2nFW0Y-I5WhFCREUkIxfoVYy7nErSiZfoghLBmWi7FbJ3Dh_swWPrRruxyXqH_YDNMSawDvAcfAl0hIh7mPQx4jQC9i5CKuA2-Ic0lmhc9trhWTsTQCdrsMkhBAy_5km7FF-jF4OeIrw5n5fox-3N9-uv1f23L3fXn-8rU3csVcAIb1hr-h7ahgyaQEtZzbmhg9Cy6UUHIPuesQFYnbcwQ2tYvqdc8rofBL9En06687LZQ2_ApaAnNQe71-GovLbq74qzo9r6g2Jc1DVps8DHs0DwPxeISe1tNDDlLcAvUQkiBeeEZvD9P-DOL8Hl5RRjUnY164ra-gSZ4GMMMPyZhBJVLFTFQlUsVMXC_ODd0_mf4CfPMvDhDOho9DSE_M82PnKctU1bGl-dsJgrbgvhcbr_dP4Nps22Mw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229984286</pqid></control><display><type>article</type><title>In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants</title><source>PubMed Central</source><creator>Van Noorden, C J F ; Jonges, T G N ; Meade-Tollin, L C ; Smith, R E ; Koehler, A</creator><creatorcontrib>Van Noorden, C J F ; Jonges, T G N ; Meade-Tollin, L C ; Smith, R E ; Koehler, A</creatorcontrib><description>An animal model was used to study the effects of oral treatment with a small molecular selective inhibitor of cysteine proteinases, Z-Phe-Arg-fluoromethylketone (Z-Phe-Arg-FMK) on primary tumour development. Poorly differentiated rapidly growing and moderately differentiated slowly growing human pancreatic tumours were implanted in the neck of nude mice that were orally treated or not with the inhibitor. Growth rates of the tumours were determined during 38 days after implantation. The poorly differentiated tumours were not affected by treatment with the inhibitor. Development of the moderately differentiated tumours was inhibited significantly by Z-Phe-Arg-FMK treatment. Moreover, the amount of stroma was increased and the volume of cancer cells was reduced in the moderately differentiated tumours that had grown in the treated animals. Reduction in size of the tumours was not achieved by reduction in growth rate but in a delay of the onset of growth. It is concluded that cysteine proteinases play a transient role at the start of tumour development only when cancer cells are surrounded by stroma as was the case in the moderately differentiated but not in the poorly differentiated pancreatic tumours. However, this role of cysteine proteinases can easily be taken over by other proteinases. © 2000 Cancer Research Campaign</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1054/bjoc.1999.1021</identifier><identifier>PMID: 10732768</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Animal tumors. Experimental tumors ; Animals ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Cell Differentiation ; Cell Division - drug effects ; Cysteine Endopeptidases - drug effects ; Cysteine Proteinase Inhibitors - pharmacology ; Drug Resistance ; Epidemiology ; Experimental tumors, general aspects ; Female ; Humans ; Medical sciences ; Mice ; Mice, Nude ; Molecular Medicine ; Oncology ; Pancreatic cancer ; Pancreatic Neoplasms - enzymology ; Pancreatic Neoplasms - pathology ; Regular ; regular-article ; Tumors</subject><ispartof>British journal of cancer, 2000-02, Vol.82 (4), p.931-936</ispartof><rights>The Author(s) 2000</rights><rights>2000 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Feb 2000</rights><rights>Copyright © 2000 Cancer Research Campaign 2000 Cancer Research Campaign</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-e203526cdde650fa0e612433c1f7a95d78ee9dd22fe24732cf6c295d13934df73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374406/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374406/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1326566$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10732768$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Van Noorden, C J F</creatorcontrib><creatorcontrib>Jonges, T G N</creatorcontrib><creatorcontrib>Meade-Tollin, L C</creatorcontrib><creatorcontrib>Smith, R E</creatorcontrib><creatorcontrib>Koehler, A</creatorcontrib><title>In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>An animal model was used to study the effects of oral treatment with a small molecular selective inhibitor of cysteine proteinases, Z-Phe-Arg-fluoromethylketone (Z-Phe-Arg-FMK) on primary tumour development. Poorly differentiated rapidly growing and moderately differentiated slowly growing human pancreatic tumours were implanted in the neck of nude mice that were orally treated or not with the inhibitor. Growth rates of the tumours were determined during 38 days after implantation. The poorly differentiated tumours were not affected by treatment with the inhibitor. Development of the moderately differentiated tumours was inhibited significantly by Z-Phe-Arg-FMK treatment. Moreover, the amount of stroma was increased and the volume of cancer cells was reduced in the moderately differentiated tumours that had grown in the treated animals. Reduction in size of the tumours was not achieved by reduction in growth rate but in a delay of the onset of growth. It is concluded that cysteine proteinases play a transient role at the start of tumour development only when cancer cells are surrounded by stroma as was the case in the moderately differentiated but not in the poorly differentiated pancreatic tumours. However, this role of cysteine proteinases can easily be taken over by other proteinases. © 2000 Cancer Research Campaign</description><subject>Animal tumors. Experimental tumors</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Cell Differentiation</subject><subject>Cell Division - drug effects</subject><subject>Cysteine Endopeptidases - drug effects</subject><subject>Cysteine Proteinase Inhibitors - pharmacology</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Experimental tumors, general aspects</subject><subject>Female</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><subject>Pancreatic cancer</subject><subject>Pancreatic Neoplasms - enzymology</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Regular</subject><subject>regular-article</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNp1kU1v1DAQhi0EokvhyhFZCHHL1h9JHF-QUNVCpUpc4Gx5ncnGq6wdbGfL_nts7YoWJE6e8Tx-Z8YvQm8pWVPS1FebnTdrKqXMKaPP0Io2nFW0Y-I5WhFCREUkIxfoVYy7nErSiZfoghLBmWi7FbJ3Dh_swWPrRruxyXqH_YDNMSawDvAcfAl0hIh7mPQx4jQC9i5CKuA2-Ic0lmhc9trhWTsTQCdrsMkhBAy_5km7FF-jF4OeIrw5n5fox-3N9-uv1f23L3fXn-8rU3csVcAIb1hr-h7ahgyaQEtZzbmhg9Cy6UUHIPuesQFYnbcwQ2tYvqdc8rofBL9En06687LZQ2_ApaAnNQe71-GovLbq74qzo9r6g2Jc1DVps8DHs0DwPxeISe1tNDDlLcAvUQkiBeeEZvD9P-DOL8Hl5RRjUnY164ra-gSZ4GMMMPyZhBJVLFTFQlUsVMXC_ODd0_mf4CfPMvDhDOho9DSE_M82PnKctU1bGl-dsJgrbgvhcbr_dP4Nps22Mw</recordid><startdate>20000201</startdate><enddate>20000201</enddate><creator>Van Noorden, C J F</creator><creator>Jonges, T G N</creator><creator>Meade-Tollin, L C</creator><creator>Smith, R E</creator><creator>Koehler, A</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20000201</creationdate><title>In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants</title><author>Van Noorden, C J F ; Jonges, T G N ; Meade-Tollin, L C ; Smith, R E ; Koehler, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-e203526cdde650fa0e612433c1f7a95d78ee9dd22fe24732cf6c295d13934df73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animal tumors. Experimental tumors</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Cell Differentiation</topic><topic>Cell Division - drug effects</topic><topic>Cysteine Endopeptidases - drug effects</topic><topic>Cysteine Proteinase Inhibitors - pharmacology</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Experimental tumors, general aspects</topic><topic>Female</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><topic>Pancreatic cancer</topic><topic>Pancreatic Neoplasms - enzymology</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Regular</topic><topic>regular-article</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van Noorden, C J F</creatorcontrib><creatorcontrib>Jonges, T G N</creatorcontrib><creatorcontrib>Meade-Tollin, L C</creatorcontrib><creatorcontrib>Smith, R E</creatorcontrib><creatorcontrib>Koehler, A</creatorcontrib><collection>SpringerOpen</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van Noorden, C J F</au><au>Jonges, T G N</au><au>Meade-Tollin, L C</au><au>Smith, R E</au><au>Koehler, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>2000-02-01</date><risdate>2000</risdate><volume>82</volume><issue>4</issue><spage>931</spage><epage>936</epage><pages>931-936</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>An animal model was used to study the effects of oral treatment with a small molecular selective inhibitor of cysteine proteinases, Z-Phe-Arg-fluoromethylketone (Z-Phe-Arg-FMK) on primary tumour development. Poorly differentiated rapidly growing and moderately differentiated slowly growing human pancreatic tumours were implanted in the neck of nude mice that were orally treated or not with the inhibitor. Growth rates of the tumours were determined during 38 days after implantation. The poorly differentiated tumours were not affected by treatment with the inhibitor. Development of the moderately differentiated tumours was inhibited significantly by Z-Phe-Arg-FMK treatment. Moreover, the amount of stroma was increased and the volume of cancer cells was reduced in the moderately differentiated tumours that had grown in the treated animals. Reduction in size of the tumours was not achieved by reduction in growth rate but in a delay of the onset of growth. It is concluded that cysteine proteinases play a transient role at the start of tumour development only when cancer cells are surrounded by stroma as was the case in the moderately differentiated but not in the poorly differentiated pancreatic tumours. However, this role of cysteine proteinases can easily be taken over by other proteinases. © 2000 Cancer Research Campaign</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>10732768</pmid><doi>10.1054/bjoc.1999.1021</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-0920 |
ispartof | British journal of cancer, 2000-02, Vol.82 (4), p.931-936 |
issn | 0007-0920 1532-1827 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2374406 |
source | PubMed Central |
subjects | Animal tumors. Experimental tumors Animals Biological and medical sciences Biomedical and Life Sciences Biomedicine Cancer Research Cell Differentiation Cell Division - drug effects Cysteine Endopeptidases - drug effects Cysteine Proteinase Inhibitors - pharmacology Drug Resistance Epidemiology Experimental tumors, general aspects Female Humans Medical sciences Mice Mice, Nude Molecular Medicine Oncology Pancreatic cancer Pancreatic Neoplasms - enzymology Pancreatic Neoplasms - pathology Regular regular-article Tumors |
title | In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A48%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%20inhibition%20of%20cysteine%20proteinases%20delays%20the%20onset%20of%20growth%20of%20human%20pancreatic%20cancer%20explants&rft.jtitle=British%20journal%20of%20cancer&rft.au=Van%20Noorden,%20C%20J%20F&rft.date=2000-02-01&rft.volume=82&rft.issue=4&rft.spage=931&rft.epage=936&rft.pages=931-936&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1054/bjoc.1999.1021&rft_dat=%3Cproquest_pubme%3E70973301%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c482t-e203526cdde650fa0e612433c1f7a95d78ee9dd22fe24732cf6c295d13934df73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=229984286&rft_id=info:pmid/10732768&rfr_iscdi=true |